[HTML][HTML] Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing, K Zhang… - Cell Reports …, 2024 - cell.com
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing… - Cell reports …, 2024 - europepmc.org
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
[HTML][HTML] Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing, K Zhang… - Cell Reports …, 2024 - Elsevier
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
[HTML][HTML] Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing, K Zhang… - Cell Reports …, 2024 - cell.com
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
[PDF][PDF] Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing, K Zhang… - Cell …, 2024 - scienceopen.com
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing… - Cell reports …, 2024 - pubmed.ncbi.nlm.nih.gov
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
[HTML][HTML] Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Z Liu, J Zhou, W Wang, G Zhang, L Xing… - Cell Reports …, 2024 - ncbi.nlm.nih.gov
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
Neutralization of SARS-CoV-2 BA. 2.86 and JN. 1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD.
Z Liu, J Zhou, W Wang, G Zhang, L Xing… - Cell reports …, 2024 - europepmc.org
The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …
subvariants BA. 2.86 and JN. 1 raise concerns regarding their potential to evade immune …